Introduction
Autoantibodies are immunoglobulins formed against the intracellular structures of the body itself, such as nucleic acids, receptors, glycoproteins, actin, or etc. They take effect by preventing the biological functions of the target pathways such as DNA synthesis, mRNA transcription, translation, and various stages of the cell cycle.
Currently, many different autoantibodies are used as clinical diagnostic markers, supporting the diagnosis, early signs of disease, classification criteria and they are utilized as prognostic factors as well (1) (2) (3) (4) . However, positivity can be seen in approximately 30% of healthy individuals at low titers such as 1/40. Indirect fluorescent antibody technique (IFA) is the best method used for detection of ANA at HEp-2 cells as a resource of antigen. Determination of different types of autoantibodies in ANA spectrum is possible. Recently, a positivity at 1/160 dilution and above is considered significant (3-7). Some proteins found in the nucleus of the cell can be extracted using saline, and are called extractable nuclear antigens (ENA). Among ENAs, Smith (Sm) antigen is a non-histon acidic ribonucleoprotein with low molecular weight; SS-A is a protein playing role in the process of mRNA, SS-B is a phosphoprotein playing role as a cofactor for RNA polymerase III; Scl-70 antigen is defined as DNA topoisomerase I, and Jo-1 is the histidyltRNA synthetase enzyme (8) . Determination anti-ENA antibodies can play a critical role in the differential diagnosis of autoimmune disorders, and is performed using the indirect immune fluorescent (IFA) method. In the present study, we aimed to compare and evaluate ANA patterns determined via IFA method for the detection of autoantibodies against ENAs.
Material and methods

Patients and samples
Antinuclear antibodies were investigated in the sera 5453 patients admitted to various clinics of Ondokuz Mayıs University Medical Faculty between October 2010 -December 2012.
Detection of antinuclear antibodies and subgroups
ANA testings was performed in serum samples using the IFA method (Euroimmun, Lübeck, Germany). The presence of ANA and different staining patterns were tested following the manufacturers' recommendations. Briefly; 1:100 dilutions of serum samples were prepared, and were incubated with HEp-2 cells for 30 min at room temperature (RT). After washing, the slides were incubated for 30 min with goat fluorescein isothiocyanate-conjugated anti-human immunoglobulin G (IgG). After washing, the slides were examined using a NikonOptiPhot-2 fluorescent microscope (Euroimmun, Lübeck, Germany).
Detection of anti-ENA antibody types
Of the ANA-positive samples a total of 616 were further tested for anti-ENA using the same method (Anti-ENA Profile Plusi IgG, Euroimmun, Lübeck, Germany). Nitrocellulose strips containing Sm, Scl-70, Jo-1, SSA, SSB, nRNP/Sm, and a control (anti-human IgG) were incubated with the buffer for 5 min at RT. 1:100 dilutions of serum samples were added, and were incubated for 30 min at RT. After washing, enzyme conjugate was added and incubated for 30 min at RT. After the addition of the stop solution, the strips were evaluated using the EUROLineScan software (Euroimmun, Lübeck, Germany).
Statistical analysis
A statistical analysis was performed using SPSS Version 15.0 (IBM, Chicago, IL, United States). Descriptive variables were presented as numbers and percentages. For the categorical variables, differences between groups and associations between the variables were analyzed using Chi Square test (χ2). An independent sample T test was used for comparison between the groups in terms of age. The results were analyzed within a confidence interval of 95%, and a p value of <0.05 was accepted as statistically significant.
Results
ANA positivity was detected in 843 specimens tested (15.5%). The mean age of the patients whom the sera were taken was 41.2±16.9 in ANA-positive group and 39.9±18.2 in ANA-negative individuals. The difference between the groups was not significant (p=0.528). 624 of the patients (74%) were female, and 219 (26%) were male. Anti-ENA antibodies were positive for 192 (31.2%) samples taken from 616 specimens which were ANA positive and of which anti-ENA testing performed. Of those, the most common-ANA patterns detected were as follows speckled pattern in 144 (75.0%) of the samples, nucleolar pattern in 20 of the samples (10.4%), and homogeneous pattern in 13 (6.8%) samples ( Figure  1 ). The most common anti-ENA antibodies were: anti-SS-A detected in 50 (26.0%) samples, RO-52 detected in 39 (20.3%) samples, and anti-scl-70 observed in 34 (17.7%) samples. The distribution of anti-ENA 
Discussion
Early diagnosis of the autoimmune disorders is critical in order to prevent complications, morbidity and mortality (9) . Detection of ANA is commonly used to contribute to the diagnosis of autoimmune diseases. For instance, ANA is reported to be positive in more than 95% of SLE cases and mixed connective tissue diseases, in 80% of Sjögren Syndrome, as well as 40-60% of RA. ANA positivity alone is not adequate, the subgroup type of ANA such as speckled, nucleolar, or homogenous pattern should also be determined for a more specific diagnosis. This is why some subgroup patterns are known to be specific for some autoimmune disorders. For instance, nucleolar pattern can be frequently associated with scleroderma and polymyositis whereas homogenous pattern can comply with RA, SLE and drug-associated lupus. However, it should be kept in mind that ANA can be detected as positive in elderly, in patients with carcinoma or in cytotoxic drug use cases. Moreover ANA positivity in 1:40 titer is reported to be present in 25-30% of healthy individuals. In addition, 5% of healthy individuals can reveal a titer higher than 1:160. In contrast, in some autoimmune diseases known to be highly associated with ANA positivity such as SLE, ANA results can come negative. Hence ANA results should always be evaluated together with patient history, 4 Available online at www.jiacm.com clinical findings and other laboratory findings in order to provide a more accurate diagnosis (8) (9) (10) (11) . In the present study, the IFA was used for detection of the autoimmune antibodies. Despite the fact that IFA tests using HEp-2 cells require experienced technical staff, its cost and possibility of subjective evaluation, makes the methods been reported as the most sensitive method (8, 10, 11) . ANA positivity rates were reported to be between 8-35% in Turkey (8-11). Karakece et al. (12) found that the rate was 33.3% in a study conducted-with more than two thousand patients. In the present study, the rate was detected as 15.5% within the range of the reports from Turkey. Mengeloglu et al. (13) stated that the most frequent ANA patterns were coarse speckled pattern (31.2%), nucleolar pattern (18.0%), fine speckled pattern (11.5%), and speckled pattern (9.7%). ANA positivity was most commonly determined in RA (8.5%), SLE (5.9%), and rheumatoid vasculitis (5.7%). Özen Barut et al. (11) reported speckled pattern (39.8%), homogenous pattern (23.9%), and nucleolar (18.8%) pattern in their study as the most common patterns. Their population consisted of-309 ANA-positive samples. Another group, Kaklikkaya et al. (14) reported that speckled staining was the most frequent pattern which was seen in 53 (29.4%) of 180 the ANA-positive samples they tested. Karakece et al. (12) also found that the most common patterns were speckled, nucleolar and homogenous among 755 ANA-positive samples. In the present study, the most frequent patterns were also speckled, nucleolar, and homogeneous patterns. These reports showed the same common ANA patterns in accordance with each other. In our study, the most frequent anti-ENA antibodies detected were anti-SS-A, RO-52 and anti-scl-70. Ro-52, SS-A, anti-Sm, anti-SS-B and Scl-70, nRNP/Sm and Jo-1 was reported as the most frequent anti-ENA antibodies by Kaklikkaya et al. (14) found as. Us et al. (8) reported anti-Sm, anti-nRNP, anti-SS-A as the most common anti-ENA antibodies, and anti-SS-B. Further tests of ENAs can be used in the specific diagnosis of some distinct types of autoimmune disorders. However, these antibodies aren't specific to the diseases in many cases. This may be due to the polyclonal activity seen during the autoimmune disorders (8) .
In the present study, the most common ANA pattern was speckled staining amongst all of the samples with speckled staining, the most common anti-ENA antibodies were detected to be anti-SS-A, Ro-52, anti-Scl-70, and anti-Sm/RNP, respectively. This distribution was in accordance with the general anti-ENA antibody frequency detected previously. This finding suggests that anti-ENA antibodies do not show a specific ANA pattern, moreover, an ANA pattern doesn't fit into a specific anti-ENA antibody type. However, the presence of various ANA patterns may sometimes be associated with a specific disease or a syndrome. Detection of these patterns can be used as prognostic markers for diagnosis. It is suggested that if ANA testing is to add evidence to support a diagnosis when the clinical and other findings probability is high. Because ANA testing is expensive. And also the IFAT, is the gold standard for screening and ENA tests are restricted and more expensive.
Conclusion
In conclusion, detection of ANA, distinguishing of the ANA patterns, determination of the ENA antibody types, and evaluation of all those findings together will have a significant impact on the diagnosis of autoimmune diseases.
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